Immunomodulatory efficiency of poly(2-oxazolines).

Linear polyethylenimine produced by partial acid hydrolysis of poly(2-ethyl-2-oxazoline) for DNA and siRNA delivery in vitro. Int J Nanomedicine (2013) 0.83

Next generation hemostatic materials based on NHS-ester functionalized poly(2-oxazoline)s. Biomacromolecules (2017) 0.75

In vitro study of partially hydrolyzed poly(2-ethyl-2-oxazolines) as materials for biomedical applications. J Mater Sci Mater Med (2015) 0.75

Anti-inflammatory cytokines. Chest (2000) 4.74

Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med (2002) 3.36

Phagocytes and oxidative stress. Am J Med (2000) 3.00

Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc Natl Acad Sci U S A (2010) 2.04

Lessons from nature: stimuli-responsive polymers and their biomedical applications. Trends Biotechnol (2002) 1.93

In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release (2008) 1.67

Smart and genetically engineered biomaterials and drug delivery systems. Eur J Pharm Sci (2003) 1.34

Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro. Cytokine (2002) 1.30

Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. J Control Release (2003) 1.24

Poly(2-oxazolines) in biological and biomedical application contexts. Adv Drug Deliv Rev (2007) 1.10

Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy. Br J Pharmacol (2009) 1.08

Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines. Infect Immun (2004) 1.08

Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers. J Biomed Mater Res (1988) 1.06

Immune response in biocompatibility. Biomaterials (1992) 1.04

Oxidative stress in phagocytes--"the enemy within". Microsc Res Tech (2002) 1.01

Innate immunity in the pathogenesis and therapy of IBD. J Gastroenterol (2003) 0.98

IL-1alpha responds to necrotic cell death. Nat Med (2007) 0.95

Cell lines as in vitro models for drug screening and toxicity studies. Drug Dev Ind Pharm (2005) 0.92

In vitro bio-immunological and cytotoxicity studies of poly(2-oxazolines). J Mater Sci Mater Med (2011) 0.87

Reactive oxygen species augment B-cell-activating factor expression. Free Radic Biol Med (2006) 0.87

Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogel. Biomacromolecules (2011) 0.85

Synthesis and bioimmunological efficiency of poly(2-oxazolines) containing a free amino group. J Mater Sci Mater Med (2009) 0.80

Nonviral gene carriers based on diblock copolymers of poly(2-ethyl-2-oxazoline) and linear polyethylenimine. Bioconjug Chem (2006) 0.79

Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracil. J Biomed Mater Res (1994) 0.78

Biochemical and histological evaluation of the synovial-like tissue around failed (loose) total joint replacement prostheses in human subjects and a canine model. Biomaterials (1990) 0.77

Vibrio cholerae O1 Ogawa detoxified lipopolysaccharide structures as inducers of cytokines and oxidative species in macrophages. J Med Microbiol (2009) 0.76

Preparation of synthetic polyoxazoline based carrier and Vibrio cholerae O-specific polysaccharide conjugate vaccine. Eur J Med Chem (2009) 0.76

In vitro bio-immunological and cytotoxicity studies of poly(2-oxazolines). J Mater Sci Mater Med (2011) 0.87

Photochemical and phototoxic properties of ethyl 1,4-dihydro-8-nitro-4-oxoquinoline-3-carboxylate, a new quinoline derivative. J Photochem Photobiol B (2010) 0.77

Immunological basis of anti-Candida vaccines focused on synthetically prepared cell wall mannan-derived manno-oligomers. Microbiol Immunol (2014) 0.76

Humoral and cell-mediated immunity following vaccination with synthetic Candida cell wall mannan derived heptamannoside-protein conjugate: immunomodulatory properties of heptamannoside-BSA conjugate. Int Immunopharmacol (2012) 0.76

Synthetically prepared glycooligosaccharides mimicking Candida albicans cell wall glycan antigens--novel tools to study host-pathogen interactions. FEMS Yeast Res (2013) 0.75